Beatriz San Martin

Beatriz San Martin – IP Specialist


Beatriz is an IP specialist, with a focus on the life sciences sector and emerging/disruptive technologies. Prior to pursuing a legal career, Beatriz was a scientist with a degree and a Wellcome Trust PhD and postdoc from the University of Cambridge specialising in genetics, cellular and molecular biology. Beatriz has significant experience litigating before the UK Courts and the Court of Justice of the European Union, having acted in a number of leading reported IP cases. Beatriz has worked on several patent cases on behalf of Eli Lilly & Company including a preliminary reference to the Court of Justice of the European Union concerning the interpretation of the SPC Regulation and a case before the Court of Appeal. She has also assisted on several medical device and medical instrumentation patent cases. Though Beatriz’s practice centres on dispute resolution, it need not necessarily involve the courts. Her expertise includes assisting clients to develop, implement and supervise international IP litigation strategies, providing validity and infringement opinions and coordinating due diligence exercises. In November 2016, Beatriz was named by BioBeat one of 50 female movers and shakers in BioBusiness for 2015 and was the only solicitor to make the list. Chambers 2016 has also ranked Beatriz for the second year running as a leading IP individual who “impresses in sophisticated patent and confidential information cases. Sources describe her as “a very creative, thoughtful litigator” who “excels in managing complex, multi-jurisdictional cases.”” Beatriz is a member of the Cellular Therapy and Regenerative Medicine Advisory Committee at the BioIndustry Association and is Fieldfisher’s representative at the Intellectual Property Lawyers’ Association (IPLA). She is also a member of the Chartered Institute of Patent Attorneys (CIPA), the International Association for the Protection of Intellectual Property (AIPPI), the European Lawyers’ Association (EPLAW) and the American Intellectual Property Lawyers’ Association (AIPLA). Beatriz regularly contributes articles to professional publications and is on the editorial advisory board of Cell & Gene Therapy Insights. For the past eight years Beatriz has coordinated a series of IP lectures for the University of Cambridge Masters in Bioscience Enterprise and lectures on the course. Her speaking engagements in the past 12 months have included a talk on pharma patent settlement agreements, a review of recent patent decisions, an overview on the patentability of stem cell inventions, a presentation on injunctions in pharma cases and the harmonisation of trade secrets law in Europe.